Veradermics is trading 9% up at $119.85 following a sharp rebound from recent volatility and pre-market strength.

  • The rally is primarily driven by sustained positive sentiment regarding the company’s late-stage hair-loss pipeline.
  • Broader risk-on market conditions are supporting the price action, despite the absence of any new company-specific announcements today.